Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey L Saver, MD
Neurology, University of California, Los Angeles, USA
Principal Investigator - Qingwu Yang, MD
Neurology, Xinqiao Hospital of the Army Medical University
Principal Investigator - Raul G Nogueira, MD
Marcus Stroke & Neuroscience Center, Grady Memorial Hospital, Emory University, Atlanta, USA
Principal Investigator - Wenjie Zi, MD
Neurology, Xinqiao Hospital of the Army Medical University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Xinqiao Hospital of Army Medical University
Chongqing, Chongqing Municipality, China
- the Second Hospital of Jiaozuo
Jiaozuo, Henan, China
- Wuhan No. 1 Hospital
Wuhan, Hubei, China
- the First Affiliated Hospital, Hengyang Medical School, University of South China
Hengyang, Hunan, China
- Xiangtan Central Hospital
Xiangtan, Hunan, China
- the 904th Hospital of Cpla
Wuxi, Jiangsu, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 May 2022
- Primary completion
- 16 Dec 2024
- Completion
- 7 Feb 2025
- Last update posted
- 3 Apr 2025
- Registered enrollment
- 550
- Registry id
- NCT04733742
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.